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ABSTRACT
Objective To explore the presentation behaviours and
pathways to detection of adults who first presented to
UK hospital eye services with severe glaucoma.
Design Semistructured interviews, based on models
of diagnostic delay, to obtain a descriptive self-reported
account of when and how participants’ glaucoma was
detected.
Results 11 patients participated (five in Aberdeen,
six in Huddersfield). Four participants reported that the
optometry appointment at which their glaucoma was
detected was their first ever eye test or their first for over
10 years. Seven participants reported attending regular
routine optometrist appointments. Their self-reported
experiences and pathways to detection describe a variety
of missed detection opportunities and delayed referral
and treatment.
Conclusions The qualitative data suggest that late
detection of glaucoma can result from delays at the
patient level but, although based on a small sample,
delays also occurred at the healthcare provider (system)
level both in terms of accuracy of case detection and
effective referral. We suggest that current attempts to
address the significant burden of over-referral of
glaucoma suspects to hospital eye services (a large
proportion of which are false positives) must also focus
on the issue of false negatives and on reducing missed
detection and service delays.
INTRODUCTION
Glaucoma is a condition where early detection and
thus access to treatment is associated with better
outcomes.1–3 Studies have identified delays attribut-
able to patients’ late presentation for eye tests,4
such delays being associated with risk factors such
as socioeconomic deprivation, African-Caribbean
ethnicity and older age.4–6 However, little is known
about the experiences of patients with severe glau-
coma at diagnosis, for example, their presentation
behaviours and pathways to detection. Greater
understanding is essential for the development of
successful interventions to optimise timely detec-
tion, diagnosis and treatment.
Existing models of ‘diagnostic delay’ describe
decisional and behavioural processes prior to treat-
ment. These include delay attributable to patients
(eg, delay in seeking care) and diagnostic and treat-
ment delay attributable to healthcare providers (at
the individual practitioner level or at the service
level).7–9 Figure 1 illustrates the stages at which
diagnostic delay of glaucoma may occur, the nature
of the delay and the behaviour required (by the
patient or healthcare provider) in order to access
appropriate treatment.
In this qualitative study, we explored accounts of
when and how glaucoma was detected in adults
who first presented to hospital eye services with
severe glaucoma.
METHODS
Sampling and recruitment
We sought narratives from adults who first pre-
sented to hospital eye care services (in Aberdeen or
Huddersfield, UK) with glaucomatous visual field
loss of −20 dB, or worse, in at least one eye, or
bilateral loss of ≥−12 dB in both eyes. Consecutive
patients meeting this eligibility criterion were iden-
tified from two glaucoma outpatient clinic lists
(Aberdeen, Huddersfield) by clinical ophthalmolo-
gists and sent an information leaflet and a letter of
invitation to participate in the study (signed by the
clinician). The purposive sample was not intended
to be representative or to estimate the distribution
of views across the population of people presenting
with late stage glaucoma. Its aim was to generate
insight into the glaucoma patients’ experiences and
presenting behaviours.
Data collection
The study was approved by North of Scotland
research ethics committee (Ref: 09/S0801/68).
Semistructured face-to-face interviews were con-
ducted, between March and November 2009, using
a topic guide based on models of patient and pro-
vider delay.7–10
We obtained a descriptive account, in the partici-
pant’s own words, of when and how their glau-
coma was detected. In addition, we collected
self-reported demographic and medical information
(eg, ethnicity, family history of glaucoma) to
describe our purposive sample. Formal consent was
obtained. Interviews were audio-recorded, tran-
scribed verbatim and anonymised using a unique
participant identifier (P01–P11) and all other iden-
tifiable information removed (eg, ophthalmologists’
names).
Data management and analysis
We used a directed content analysis approach based
on existing models of diagnostic delay7–9 to iden-
tify the behaviours and experiences that led to
detection of the participants’ glaucoma (detection
pathways).11 Directed content analysis involves the
use of existing theory or prior research to provide
initial coding categories. However, this did not pre-
clude the emergence of new themes. One
researcher (MP) worked systematically through all
transcripts and created charts to summarise issues
that related to participants’ presentation
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behaviours, experiences and pathways to detection. For reliabil-
ity, another researcher ( JB) read and coded a sample of tran-
scripts. The findings were consistent.
RESULTS
Sample characteristics
Fourteen patients were invited to participate in the study
(Aberdeen: eight; Huddersfield: six). Of these, 11 expressed an
interest in taking part (Aberdeen: five; Huddersfield: six). All
11 were interviewed. No further contact was made with the
other three patients. The 11 participants included seven women
and four men. Table 1 presents their self-reported characteris-
tics. A summary of each participant’s self-reported case history
and detection pathway is presented in table 2.
Presentation behaviours and detection pathways
Participants’ accounts of when and how their glaucoma was
detected were diverse. Most described the detection and subse-
quent diagnosis of advanced glaucoma as memorable and often
distressing events, but were keen to have the opportunity to
discuss and share.
Four participants reported that the optometry appointment at
which their glaucoma was detected was their first ever eye test or
their first for over 10 years. Seven participants reported attending
regular routine optometrist appointments. Their descriptions of
experiences and pathways to detection included a variety of
missed detection opportunities, which in some cases were com-
bined with delays in accessing specialist ophthalmology services
for treatment and monitoring. Quotes from interviews are pre-
sented below to illustrate the study findings.
Patient delay
Delay in seeking care
Participants had difficulty recalling how long it took for them to
notice a problem with their eyesight. Nevertheless, accounts
from all four patients who did not regularly attend optometry
services included reports of noticeable changes in vision being
the stimulus to making a non-routine optometry appointment
that led to their glaucoma being detected and immediate referral
to hospital eye services.
I started having blurry…running eyes…I noticed occasionally it
would be cloudy…I was in [supermarket] one day so I just went
to the optician and said I need glasses, so when the guy test my
eye…they referred me up to the eye clinic. (P01)
I went to the optician thinking I was needing glasses for the
TV… I never wore glasses in my life…I thought well I’m getting
on in age, I thought I was needing reading glasses. (P05)
For one participant, it was the work supervisor rather than
the participant who first noticed a problem and arranged an
optometrist appointment.
[Supervisor suggested] I go for an eye test as there’s something
wrong. I was shocked, I said I can see properly…I don’t think
I need an eye test, I don’t use glasses… my Supervisor called the
optician in the [shopping] centre…he made an appointment. (P03)
Table 1 Participants’ self-reported characteristics
ID Gender, year of glaucoma diagnosis, eyes affected Age group* (years) Ethnic group* Myopia* Family history of glaucoma*
01 Man, 2006, one eye 40–49 Black British-Black African No No
02 Man, 2008, both eyes <40 Black British-Black African No No
03 Man, 2005, both eyes >70 White British Yes No
04 Woman, 2005, both eyes >70 White British No No
05 Woman, 2004, both eyes >70 Irish No No
06 Woman, 2003, both eyes 50–59 White British No Yes
07 Woman, 1997, both eyes >70 White British No No
08 Woman, 2006, both eyes 60–70 White British No No
09 Woman, 2007, both eyes >70 White British No Yes
10 Man, 2006, 1 eye >70 White British Yes Yes
11 Woman, 2009, both eyes 60–70 Black British-Black African Do not know Do not know
*Risk factors for developing the most common form of glaucoma (open-angle glaucoma).
Figure 1 Detection and treatment pathway for glaucoma and stages of diagnostic delay. Adapted from refs. 7–10
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Healthcare provider delay
Delays in detection and treatment were suggested to have
occurred for two main reasons: a failure to detect glaucoma at
routine optometry appointments (detection delay) and referral
or waiting time delays following detection (service delay).
Detection delay
The main ‘trigger’ for glaucoma detection in participants who
reported attending regular routine optometry appointments was
a change in optometrist or a General Practitioner (GP) appoint-
ment. Participants’ narratives provided compelling accounts of
detection delay.
It was detected when the optician looking after me at the time
retired and somebody came to take his place and said I think that
you have glaucoma… it was on my records for quite a number of
years … getting more noticeable. (P07)
It was picked [up] initially when I attend[ed] for a routine
[appointment] at my Optician, but he was a new Optician to
me…he was the first person who took a photograph of my
retina…he wasn’t happy with my optic discs… he did visual field
tests that confirmed that I had big areas in the upper outer quad-
rants completely blacked off which I was totally unaware of… he
reckoned I’d probably had it for about 4 or 5 years. (P02)
The woman [optometrist] said I had cataract in one eye…next
year I went back and the cataract was slightly worse…I had to
stop driving, because I couldn’t cope with the sun …so I went to
the doctor [GP]…he thought that the cataract was bad so he
referred me to the cataract clinic and the doctor there said I’d
had it [glaucoma] a long time, it was well advanced...she referred
me to the Glaucoma clinic and I was told that I had severe glau-
coma in both eyes. (P04)
A few participants described reporting symptoms to optome-
trists during routine appointments that in retrospect they found
Table 2 Case histories
ID Case history and detection pathway Post-detection pathway to specialist glaucoma services
01 Detected on first ever visit to optometrist
Noticing eyes watering and blurry when reading.
Spontaneous decision to go to supermarket optometrist
Patient told by optometrist to phone eye clinic for an appointment
3 months from referral (patient phone call) to eye clinic appointment
02 Routine eye tests every 1–2 years. Wore glasses. Advanced normal tension
glaucoma detected by ‘photograph’ at first visit to ‘new’ optometrist
Patient opted for private first consultation to minimise any opportunity for delay.
Saw private consultant within 2 weeks. Commenced on ocular hypotensive
therapy (Travoprost) and referred to specialist National Health Service eye clinic
03 Detected on first ever visit. Patient had not noticed anything was wrong.
Supervisor at work noticed increasing frequency of mistakes at work, suggested
eye test and booked an appointment
Got letter back from hospital eye clinic within 2 weeks of optometrist referral.
Appointment was in 2 months’ time
04 Same optometrist for 8 or 9 years.
Reporting severe headaches over eyes at last two appointments and problems
with glare. Made GP appointment to discuss severity of symptoms
GP referred patient to cataract clinic
Glaucoma detected at cataract clinic
Cataract clinic appointment from GP took 4 months
Cataract clinic initiated ocular hypotensive therapy and referred patient to
glaucoma clinic (patient reports having to stay at cataract clinic for 3.5 h while
they tried to reduce pressures)
05 Detected at first optometrist appointment Patient unsure of exact timescale but ‘not long’
06 Been to optometrist since age of 8. Annual visit from age of 40 due to family
history of glaucoma
1992: optic disc haemorrhage detected by optometrist. Patient reports no action
taken by GP or two optometrists (second optometry opinion sought by patient
due to family history)
1994–2003: optic nerve changes noted (increasing cup to disc ratio and
between-eye asymmetry in 1999). Patient reporting pain in right eye+headaches
+increasing problems with night and then all glare
2000–2002: reporting falls, difficulty crossing road, glare, accommodating to
bright/dim light
2003: glaucoma detected by high street optometrist near to her place of work.
Appointment made after patient broke her glasses in a fall
Advanced glaucoma diagnosed at first appointment with consultant
ophthalmologist
15 weeks between detection by optometrist and being seen at glaucoma clinic
07 Routine eye test every 2 years. Same optometrist for many years. He retired,
glaucoma detected on next routine visit to his replacement
Attended hospital eye clinic within 2 days of seeing new optometrist
08 Referred to hospital with high pressures 30 years ago, attended eye clinic, but
reports being discharged after a few visits. Routine sight tests every 2–3 years
since then
When glaucoma detected it was 3 years since last full eye check
Patient given letter to take to GP. Patient saw GP the next day
Eye clinic phoned patient, 7 days after she saw GP, asking her to attend eye clinic
the following week
09 Wore glasses for reading, but had not had an eye test for >10 years
Started to notice things looked a different colour through one eye Optometrist
referred patient to cataract clinic
Saw GP within 3 days of seeing optometrist
Patient received letter from hospital with a ‘password’. Patient then had to ring
hospital to make appointment
Attended hospital appointment (at cataract clinic) within 2–3 weeks, but on first
visit was told she was in the wrong place and ‘quickly’ referred her on to her
current glaucoma specialist
10 Annual eye checks, cataracts and glaucoma detected at routine visit. Detected by
an optometrist that patient had seen on previous appointments
Optometrist referred patient to GP (by letter)
GP wrote to patient informing him that an appointment had been made at the
hospital. Attended hospital appointment approximately 2 months later
11 Detected at annual eye check
With hindsight patient reports pain above the eyes at night (throbbing) for
1 month prior to optometrist appointment, thought it was ear ache
Optometrist referred to GP. GP contacted the hospital
Patient reports attending ophthalmology clinic the day after GP informed by
optometrist. Given letter from optometrist/GP to take with her
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significant, but which their optometrist did not attribute to glau-
coma and which had not led to timely detection.
I’ve been going to the same Optician for several years, about 8 or
9 years… I said that I’d had headaches, severe headache across
my left eye…she said well there’s nothing wrong with your
eyes…you may have a migraine. (P04)
…from 1994 onwards I was reporting that this eye hurt, it felt
like [I] had been thumped… and I kept saying this so every time
he [optometrist] was saying to me ‘anything to report’ my answer
to that grew… I also reported trouble with night glare…
I reported more problems with general glare…I thought I was
doing the right thing, going to the optician, reporting these
symptoms; I was having problems with night driving and the
headlight glare and so on so…I said I used to be fine with it but
I’m not anymore…So the list was growing, but he didn’t write a
thing down…In about March 2002 I fell over…I fell again, and
this time I fell and I smashed me face and did myself quite a big
injury and I went to [named chain of optometrists]…I explained
all these symptoms to them…Then she [different optometrist]
examined my eyes and she said there was nothing the matter
with them…when I came out of [chain of optometrists] in 2002
when she told me, she’d explained away all me symptoms…
I came out and I said to myself, I actually gave myself a talking to
and said, you’re getting older, you’re going to have to learn
to accept that this is what ageing is, is like. Why do you expect
to have young eyes all the time? (P06)
It is worthy of note that the quote above comes from a
patient (P06) who reported that her father and grandmother
were blind from glaucoma and that in 1992 her optometrist
noted an optic disc haemorrhage in her right eye.
I’m the third generation in a row to go blind with this now…
I knew glaucoma was a slow advancing disease and I’d been
going to the Optometrist since I was 8…therefore in all those
years I expected them to have noticed something (P06)
Asked when and how her glaucoma was detected she states:
Late on, when 95% of the optic nerve had been destroyed, in
both eyes… In 2003, they [optometrist] did the visual fields and
they did the photograph of the retina…they said they were refer-
ring me to a doctor because the back of my eyes was a bit of a
mess…there’s been a massive collapse of the visual fields. (P06)
Service delay
Patients’ referral pathways from optometry detection to specia-
lised eye service appointment varied by location. In Scotland,
participants reported being referred directly to specialist services
by their optometrist, while in England, referral from optometry
to hospital eye services, as reported by all participants, had to
be via their GP.
Two participants (P09 and P04) were initially referred to cata-
ract clinics before being redirected, with minimal delay, to spe-
cialist glaucoma services. Waiting times for the initial cataract
appointments were reported as 2 weeks and 5 months, respect-
ively. One patient reported having ocular hypotensive therapy
initiated at the cataract clinic.
…she [ophthalmologist at cataract clinic] said that I [had] severe
glaucoma…she did say that if the pressure hadn’t come down
[with ocular hypotensive therapy] I wouldn’t have been able to
go home…I was in from 12.30 until about 4 o’clock. (P04)
For other participants, waiting times between optometry
referral and attendance at specialist glaucoma clinics varied from
a couple of days to 4 months. However, it is not possible to
ascertain from these data whether waiting times reflected the
availability of specialist appointments per se (eg, minimum
waiting time for all referrals) or the details of the referral (eg,
the level of urgency communicated by optometrists or GPs).
So when I went to my GP, which was very quickly after that eye
examination within 3 or 4 days. He remarked how he was sur-
prised to see me so quickly and he referred me to the hospital…
with the glaucoma specialist but I was marked in a ‘no urgency’
level so it was actually 15 weeks when I saw somebody. (P06)
Summary of results
The data suggest that late detection of glaucoma can result from
delays at the patient level but these findings, although based on
a small sample, suggest that delays also occurred at the health-
care provider (system) level both in terms of accuracy of case
detection and timely referral.
DISCUSSION
By exploring accounts of the pathways to detection for patients
diagnosed with glaucoma at a late stage, this study makes an
important contribution to the evidence on late presentation.
Other studies have suggested that late presentation is linked to
socioeconomic deprivation and frequency of attending for sight
tests in community optometry (ie, patient attributes).4 5 One
interpretation of this published evidence is that increased
patient awareness and education programmes might encourage
earlier detection. Also interventions to break down barriers to
access to optometry services at the patient level in areas with
high deprivation are being tested.12
However, this study highlights that it may be appropriate to
design interventions to change behaviour not (only) at the
patient level but at the healthcare provider levels (healthcare
professionals and referral systems). For example, simple decision
support tools, alerts and prompts (delivered as leaflets, wall
stickers or through computer systems) could be designed to
support optometrists’ and GPs’ decision making.
Technology could help improve detection. The use of auto-
mated optic nerve and retinal nerve fibre layer imaging, particu-
larly in eyes with low intraocular pressure where the glaucoma
may be missed, could improve timely glaucoma detection.
However, the equipment is costly and there is considerable
uncertainty about its place in eye services. A large multicentre
comparative study of these imaging technologies for the diagno-
sis of glaucoma is ongoing and will report in 2015.13
Implications for policy
Strategies to implement the National Institute of Health and
Care Excellence guidelines for glaucoma treatment14 may raise
awareness and knowledge of glaucoma at both the patient and
healthcare provider levels. In particular, inclusion of perimetry
and optic nerve assessment as part of the optometry test sched-
ule is likely to improve the timeliness and accuracy of referral.
In England, the role of GPs as gatekeepers of care means the
referral pathway goes through a generalist (GP) instead of from
‘specialist in eyes’ (optometry) to ‘specialist in eyes’ (ophthal-
mology). While referral refinement systems are in place across
the UK with direct referral from optometrists to a specialist eye
service, patients’ narratives (eg, table 2) indicated there was con-
siderable variation in the post-detection pathway. Consideration
should be given to streamlining and standardising this process.
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Strengths and limitations of the study
The qualitative design is a strength of this exploratory study as
it provided vivid, compelling and rich accounts of patients’
experiences and new insights into the reality of diagnostic delay.
The small sample size reflected the exploratory nature of the
study. The sample was not selected to be statistically representa-
tive and we do not claim that our findings are generalisable.
The participants’ accounts suggest that they may have either
open-angle glaucoma or angle-closure glaucoma but all had
advanced glaucoma which could have been avoided by early
detection and treatment.
CONCLUSION
The study findings are presented at a time when the main detec-
tion pathway issue for glaucoma being addressed in the ophthal-
mology literature is the significant burden of over-referral of
glaucoma suspects to hospital eye services (a large proportion of
which are false positives).15
In contrast, patients such as those included in this study, who
reported attending regular eye tests, but who experienced
detection delay and first presented at hospital eye services with
advanced glaucoma, represent false negatives. Such patients
have been denied the opportunity to access early diagnosis and
treatment and thus to limit the extent of their visual impair-
ment. We suggest that attempts to address the significant burden
of false positives, by refining glaucoma detection and referral by
optometrists,15 must also focus on the issue of false negatives
and on reducing missed detection and service delays.
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